This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Asia
20 - 22 October, 2025
Presented in Japan Standard TimeThe Westin Miyako Kyoto

Delivered as a Hybrid Event

Vivian Lee
Senior Research Scientist, Protein Therapeutics at Gilead Sciences
Speaker

Profile

Vivian Lee has over 20 years drug development experiences in biotech/pharmaceutical industry including Onyx Pharmaceuticals, Genentech and 23andme. She has established human synthetic antibody phage libraries, a two in one antibody technology, T-cell engager platforms and lead optimization strategies. She currently works as Senior Research Scientist in Protein Therapeutics Department at Gilead Sciences, leading biologics discovery in various therapeutic areas including oncology, inflammation and virology.

Agenda Sessions

  • Unleashing Therapeutic Potential: Bispecific Antibodies Targeting Herpes Simplex Virus Infection for Chronic Suppressive Therapy

    15:00